ES546728A0 - Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo. - Google Patents

Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.

Info

Publication number: ES546728A0
Authority: ES; Spain
Prior art keywords: nucleus; active substance; biphassic; pharmacy; pores
Prior art date: 1984-09-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES546728A

Other languages

English (en)

Other versions

ES8702138A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Leo AB

Original Assignee

Leo AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-09-06

Filing date

1985-09-05

Publication date

1986-12-16

1985-09-05 Application filed by Leo AB filed Critical Leo AB

1986-12-16 Publication of ES8702138A1 publication Critical patent/ES8702138A1/es

1986-12-16 Publication of ES546728A0 publication Critical patent/ES546728A0/es

Status Expired legal-status Critical Current

Links

239000013543 active substance Substances 0.000 title abstract 3
239000011248 coating agent Substances 0.000 title abstract 2
238000000576 coating method Methods 0.000 title abstract 2
239000012528 membrane Substances 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000003814 drug Substances 0.000 abstract 4
229940079593 drug Drugs 0.000 abstract 4
239000002245 particle Substances 0.000 abstract 2
238000002360 preparation method Methods 0.000 abstract 2
230000002051 biphasic effect Effects 0.000 abstract 1
239000010419 fine particle Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
229920003176 water-insoluble polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Processes Of Treating Macromolecular Substances (AREA)
Control Of Temperature (AREA)
Slot Machines And Peripheral Devices (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ES546728A 1984-09-06 1985-09-05 Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo. Expired ES8702138A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE8404467A SE8404467D0 (sv)	1984-09-06	1984-09-06	Controlled-release medical preparations

Publications (2)

Publication Number	Publication Date
ES8702138A1 ES8702138A1 (es)	1986-12-16
ES546728A0 true ES546728A0 (es)	1986-12-16

Family

ID=20356934

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES546728A Expired ES8702138A1 (es)	1984-09-06	1985-09-05	Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.

Country Status (21)

Country	Link
US (1)	US4824678A (es)
EP (1)	EP0173928B1 (es)
JP (1)	JP2527713B2 (es)
KR (1)	KR930003114B1 (es)
AT (1)	ATE53490T1 (es)
AU (1)	AU576891B2 (es)
CA (1)	CA1252723A (es)
DE (1)	DE3578123D1 (es)
DK (1)	DK164256C (es)
ES (1)	ES8702138A1 (es)
FI (1)	FI87042C (es)
GR (1)	GR852158B (es)
HU (1)	HU194495B (es)
IE (1)	IE58263B1 (es)
IL (2)	IL76257A (es)
NO (1)	NO169996C (es)
NZ (1)	NZ213245A (es)
PH (1)	PH22119A (es)
PT (1)	PT81092B (es)
SE (1)	SE8404467D0 (es)
ZA (1)	ZA856547B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4917899A (en) *	1983-12-22	1990-04-17	Elan Corporation Plc	Controlled absorption diltiazem formulation
IE56999B1 (en) *	1983-12-22	1992-03-11	Elan Corp Plc	Pharmaceutical formulation
DK62184D0 (da) *	1984-02-10	1984-02-10	Benzon As Alfred	Diffusionsovertrukket polydepotpraeparat
AU571312B2 (en) *	1984-02-10	1988-04-14	Nycomed Danmark A/S	Diffusion coated multiple-units dosage form
US5624683A (en) *	1986-08-06	1997-04-29	Eisai Co., Ltd.	Sustained-release multi-granule tablet
DE3720757A1 (de) *	1987-06-24	1989-01-05	Bayer Ag	Dhp-manteltablette
US5073381A (en) *	1988-08-15	1991-12-17	University Of Akron	Amphiphilic networks
US5612059A (en) *	1988-08-30	1997-03-18	Pfizer Inc.	Use of asymmetric membranes in delivery devices
US5178868A (en) *	1988-10-26	1993-01-12	Kabi Pharmacia Aktiebolaq	Dosage form
SE8803822D0 (sv) *	1988-10-26	1988-10-26		Novel dosage form
US5240601A (en) *	1988-11-09	1993-08-31	Chembiomed, Ltd.	Affinity supports for hemoperfusion
US5149425A (en) *	1988-11-09	1992-09-22	Chembiomed, Ltd.	Affinity supports for hemoperfusion
ATE118345T1 (de) *	1990-08-07	1995-03-15	Pfizer	Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5288505A (en) *	1991-06-26	1994-02-22	Galephar P.R., Inc., Ltd.	Extended release form of diltiazem
US5407686A (en) *	1991-11-27	1995-04-18	Sidmak Laboratories, Inc.	Sustained release composition for oral administration of active ingredient
ZA933725B (en) *	1992-05-28	1993-12-15	Elan Corp Plc	Tablet formulation
ES2113094T3 (es) *	1993-03-09	1998-04-16	Epic Therapeutics Inc	Las microparticulas macromoleculares y metodos de obtencion.
US6090925A (en)	1993-03-09	2000-07-18	Epic Therapeutics, Inc.	Macromolecular microparticles and methods of production and use
US5547948A (en) *	1995-01-17	1996-08-20	American Home Products Corporation	Controlled release of steroids from sugar coatings
EP1005863A1 (en) *	1998-12-04	2000-06-07	Synthelabo	Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) *	1999-09-29	1999-12-01	Novartis Ag	New oral formulations
US20060153914A1 (en) *	1999-12-10	2006-07-13	Biovail Laboratories International S.R.L.	Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en)	1999-12-10	2006-09-19	Biovall Laboratories International Srl	Chronotherapeutic diltiazem formulations and the administration thereof
WO2001045668A2 (en)	1999-12-20	2001-06-28	Schering Corporation	Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en)	1999-12-20	2001-07-03	Schering Corporation	Extended release oral dosage composition
SE0100200D0 (sv)	2001-01-24	2001-01-24	Astrazeneca Ab	New film coating
US6960357B2 (en)	2001-05-25	2005-11-01	Mistral Pharma Inc.	Chemical delivery device
RU2325152C2 (ru) *	2001-07-04	2008-05-27	Сан Фармасьютикл Индастриз Лимитид	Удерживаемая в желудке система регулируемой доставки лекарственного средства
US6602911B2 (en) *	2001-11-05	2003-08-05	Cypress Bioscience, Inc.	Methods of treating fibromyalgia
EP1355633B1 (en)	2001-12-19	2005-01-19	AstraZeneca AB	NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
CA2479350A1 (en) *	2002-03-15	2003-09-25	Cypress Bioscience, Inc.	Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20040121010A1 (en) *	2002-10-25	2004-06-24	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
US20060003004A1 (en) *	2002-10-25	2006-01-05	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
GB0227948D0 (en) *	2002-11-29	2003-01-08	Cipla Ltd	Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
WO2004067039A1 (en) *	2003-01-28	2004-08-12	Collegium Pharmaceutical, Inc.	Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) *	2004-10-27	2011-01-04	Boston Scientific Scimed, Inc.	Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) *	2005-09-28	2011-08-09	Cypress Bioscience, Inc.	Milnacipran for the long-term treatment of fibromyalgia syndrome
ATE438381T1 (de) *	2005-11-18	2009-08-15	Synhton B V	Zolpidemtabletten
US7427414B2 (en) *	2006-01-18	2008-09-23	Astron Research Limited	Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) *	2011-12-19	2012-05-09	岳阳新华达制药有限公司	含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
TR201801650T1 (tr)	2015-08-07	2018-03-21	Santa Farma Ilac Sanayii Anonim Sirketi	Kontrollü salim propi̇veri̇n formülasyonlari
EP3796908B1 (en)	2018-11-16	2023-05-10	Santa Farma Ilaç Sanayi A.S.	Controlled release propiverine formulations
EP4251154A4 (en)	2020-11-27	2024-07-31	Santa Farma Ilac Sanayii A.S.	SUSTAINED-RELEASE FORMULATION COMPOSITIONS COMPRISING PROPIVERINE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL108838C (es) *	1956-03-27
US3538214A (en) *	1969-04-22	1970-11-03	Merck & Co Inc	Controlled release medicinal tablets
EP0013131A3 (en) *	1978-12-27	1981-01-07	Mundipharma A.G.	Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) *	1982-07-08	1985-12-10	Ab Ferrosan	Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) *	1983-08-16	1995-01-25	ザウエルカムフアウンデ−シヨンリミテツド	調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) *	1984-08-15	1988-09-06	Burroughs Wellcome Co.	Delivery system

1984
- 1984-09-06 SE SE8404467A patent/SE8404467D0/xx unknown
1985
- 1985-08-22 IE IE207085A patent/IE58263B1/en not_active IP Right Cessation
- 1985-08-23 EP EP85110631A patent/EP0173928B1/en not_active Expired - Lifetime
- 1985-08-23 AT AT85110631T patent/ATE53490T1/de not_active IP Right Cessation
- 1985-08-23 DE DE8585110631T patent/DE3578123D1/de not_active Expired - Fee Related
- 1985-08-27 NZ NZ213245A patent/NZ213245A/xx unknown
- 1985-08-28 ZA ZA856547A patent/ZA856547B/xx unknown
- 1985-08-29 NO NO853407A patent/NO169996C/no not_active IP Right Cessation
- 1985-08-30 IL IL76257A patent/IL76257A/xx not_active IP Right Cessation
- 1985-08-30 AU AU46935/85A patent/AU576891B2/en not_active Ceased
- 1985-08-30 IL IL76256A patent/IL76256A/xx not_active IP Right Cessation
- 1985-09-02 DK DK400685A patent/DK164256C/da not_active IP Right Cessation
- 1985-09-04 CA CA000489993A patent/CA1252723A/en not_active Expired
- 1985-09-04 PH PH32739A patent/PH22119A/en unknown
- 1985-09-05 KR KR1019850006485A patent/KR930003114B1/ko not_active Expired - Fee Related
- 1985-09-05 US US06/772,779 patent/US4824678A/en not_active Expired - Lifetime
- 1985-09-05 HU HU853358A patent/HU194495B/hu not_active IP Right Cessation
- 1985-09-05 PT PT81092A patent/PT81092B/pt not_active IP Right Cessation
- 1985-09-05 FI FI853406A patent/FI87042C/fi not_active IP Right Cessation
- 1985-09-05 ES ES546728A patent/ES8702138A1/es not_active Expired
- 1985-09-06 JP JP60197517A patent/JP2527713B2/ja not_active Expired - Lifetime
- 1985-09-06 GR GR852158A patent/GR852158B/el unknown

Also Published As

Publication number	Publication date
NO853407L (no)	1986-03-07
SE8404467D0 (sv)	1984-09-06
IL76256A0 (en)	1986-01-31
HU194495B (en)	1988-02-29
EP0173928A1 (en)	1986-03-12
FI853406L (fi)	1986-03-07
NO169996C (no)	1992-09-02
GR852158B (es)	1986-01-08
CA1252723A (en)	1989-04-18
EP0173928B1 (en)	1990-06-13
IL76256A (en)	1990-06-10
ES8702138A1 (es)	1986-12-16
IE58263B1 (en)	1993-08-25
US4824678A (en)	1989-04-25
PT81092A (en)	1985-10-01
DK400685A (da)	1986-03-07
FI87042B (fi)	1992-08-14
IL76257A (en)	1989-05-15
ATE53490T1 (de)	1990-06-15
DE3578123D1 (de)	1990-07-19
PT81092B (pt)	1988-01-22
DK164256B (da)	1992-06-01
ZA856547B (en)	1986-04-30
DK164256C (da)	1992-10-19
AU4693585A (en)	1986-03-13
DK400685D0 (da)	1985-09-02
NO169996B (no)	1992-05-25
KR930003114B1 (ko)	1993-04-19
PH22119A (en)	1988-06-01
FI87042C (fi)	1992-11-25
FI853406A0 (fi)	1985-09-05
IE852070L (en)	1986-03-06
JPS61112013A (ja)	1986-05-30
AU576891B2 (en)	1988-09-08
KR860002271A (ko)	1986-04-24
NZ213245A (en)	1988-06-30
JP2527713B2 (ja)	1996-08-28
HUT40333A (en)	1986-12-28

Publication	Publication Date	Title
ES546728A0 (es)	1986-12-16	Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.
CA2033277A1 (en)	1991-06-29	Controlled release pharmaceutical preparation and method for producing the same
AU646399B2 (en)	1994-02-24	Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
KR880004804A (ko)	1988-06-27	분무건조 아세트 아미노펜
NO20002788D0 (no)	2000-05-31	Nye forbindelser
NO863997L (no)	1987-04-13	Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ATE131726T1 (de)	1996-01-15	Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung
ES2029789T3 (es)	1992-10-01	Metodo para obtener un preparado farmaceutico de liberacion prolongada.
ATE77239T1 (de)	1992-07-15	Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
Kurumaddali et al.	1994	Preparation and evaluation of sustained release ibuprofen beads
EP0080117A3 (en)	1984-07-25	Enantiomers of trans-indeno(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them
DE2836387A1 (de)	1980-02-28	Retardform fuer einen blutdrucksenkenden und antanginoes wirkenden stoff
ATE3208T1 (de)	1983-05-15	Pyrido (2,3-d) pyrimidin-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung der pyrido (2,3-d) pyrimidin-derivate.
ATE9157T1 (de)	1984-09-15	Pyrimidonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
ATE11406T1 (de)	1985-02-15	6,7,8,9-tetrahydro-3h-benz(e)indolaminderivate, verfahren zu ihrer herstellung und dabei verwendete zwischenverbindungen und pharmazeutische zubereitungen, die die indolaminderivate enthalten.
NL154507B (nl)	1977-09-15	Werkwijze voor de bereiding van een farmaceutisch preparaat dat een farmacologisch werkzaam derivaat van een tricyclisch gecondenseerd ringsysteem bevattend aminocarbonzuur bevat alsmede het verkregen gevormde farmaceutische preparaat, en werkwijze voor de bereiding van een voor opnemen in zo'n preparaat geschikt derivaat van een een tricyclisch gecondenseerd ringsysteem bevattend aminocarbonzuur.